Hydrogel-forming microneedles (HF-MNs) are composed of unique cross-linked polymers that are devoid of the active pharmaceutical ingredient (API) within the microneedle array. Instead, the API is housed in a reservoir affixed on the top of the baseplate of the HF-MNs. To date, various types of drug-reservoirs and multiple solubility-enhancing approaches have been employed to deliver hydrophobic molecules combined with HF-MNs. These strategies are not without drawbacks, as they require multiple manufacturing steps, from solubility enhancement to reservoir production. However, this current study challenges this trend and focuses on the delivery of the hydrophobic antibiotic rifampicin using SmartFilm-technology as a solubility-enhancing strategy. In contrast to previous techniques, smart drug-reservoirs (SmartReservoirs) for hydrophobic compounds can be manufactured using a one step process. In this study, HF-MNs and three different concentrations of rifampicin SmartFilms (SFs) were produced. Following this, both HF-MNs and SFs were fully characterised regarding their physicochemical and mechanical properties, morphology, Raman surface mapping, the interaction with the cellulose matrix and maintenance of the loaded drug in the amorphous form. In addition, their drug loading and transdermal permeation efficacy were studied. The resulting SFs showed that the API was intact inside the cellulose matrix within the SFs, with the majority of the drug in the amorphous state. SFs alone demonstrated no transdermal penetration and less than 20 ± 4 μg of rifampicin deposited in the skin layers. In contrast, the transdermal permeation profile using SFs combined with HF-MNs (. SmartReservoirs) demonstrated a 4-fold increase in rifampicin deposition (80 ± 7 μg) in the skin layers and a permeation of approx. 500 ± 22 μg. Results therefore illustrate that SFs can be viewed as novel drug-reservoirs ( SmartReservoirs) for HF-MNs, achieving highly efficient loading and diffusion properties through the hydrogel matrix.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d4tb00110aDOI Listing

Publication Analysis

Top Keywords

hydrogel-forming microneedles
8
combined hf-mns
8
drug-reservoirs smartreservoirs
8
cellulose matrix
8
drug amorphous
8
transdermal permeation
8
skin layers
8
hf-mns
7
sfs
7
rifampicin
5

Similar Publications

Article Synopsis
  • Microneedle (MN) technology, particularly hydrogel-forming microneedles (HFMNs), offers an innovative non-invasive method for delivering drugs through the skin, promising significant improvements in treating various dermatological conditions like acne and psoriasis.!* -
  • HFMNs are composed of small needles made from hydrophilic polymers that can penetrate the skin’s outer layer without harming underlying tissues; they absorb fluid to form a hydrogel that aids in transporting therapeutic agents directly into the dermal microcirculation.!* -
  • The technology is designed to reduce patient discomfort compared to traditional needles, enabling better drug delivery with controlled release profiles, and it also allows for real-time monitoring of interstitial fluid, enhancing the
View Article and Find Full Text PDF

Evaluation of physical and chemical modifications to drug reservoirs for stimuli-responsive microneedles.

Drug Deliv Transl Res

November 2024

School of Pharmacy, Medical Biology Centre, Queens University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, United Kingdom.

Hydrogel-forming microneedle (MN) arrays are minimally-invasive devices that can penetrate the stratum corneum, the main barrier to topical drug application, without causing pain. However, drug delivery using hydrogel-forming MN arrays tends to be relatively slow compared to rapid drug delivery using conventional needles and syringes. Therefore, in this work, for the first time, different physical and chemical delivery enhancement methods were employed in combination with PVA-based hydrogel-forming MN arrays.

View Article and Find Full Text PDF

Hydrogel-forming microneedles are constructed from or coated with polymeric, hydrophilic materials that swell upon insertion into the skin. Designed to dissolve or disintegrate postinsertion, these microneedles can deliver drugs, vaccines, or other therapeutics. Recent advancements have broadened their application scope to include the collection, transport, and extraction of dermal interstitial fluid (ISF) for medical diagnostics.

View Article and Find Full Text PDF

With the developing manufacturing technologies, the use of 3D printers in microneedle production is becoming widespread. Hydrogel-forming microneedles (HFMs), a variant of microneedles, demonstrate distinctive features such as a high loading capacity and controlled drug release. In this study, the conical microneedle master molds with approximately 500 μm needle height and 250 μm base diameter were created using a Stereolithography (SLA) 3D printer and were utilized to fabricate composite HFMs containing diclofenac sodium.

View Article and Find Full Text PDF

Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics.

Eur J Pharm Biopharm

November 2024

SSPC, the SFI Research Centre for Pharmaceuticals, School of Pharmacy, University College Cork, Cork T12 YT20, Ireland.

Protein therapeutics are essential in the treatment of various diseases, but most of them require parenteral administration. Since intravenous and subcutaneous injections are associated with discomfort and pain, other routes have been investigated including intradermal microneedle delivery. Microneedles are shorter than hypodermic needles and therefore minimize contact with pain receptors in deeper skin layers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!